INSM Technical Analysis
Insmed Incorporated — Multi-timeframe technical indicators from FMP and Massive
Signal Summary
INSM trades below both the 20-day SMA ($112.40) and 50-day SMA ($125.60), indicating bearish short-term momentum. The stock remains above the 200-day SMA ($98.30), suggesting the long-term trend is still intact despite the YTD decline of roughly 38%. RSI at44.8 sits below the neutral 50 level, pointing to continued selling pressure. The daily MACD line is below the signal line, confirming bearish momentum on shorter timeframes. INSM is a biotech with negative earnings and binary pipeline catalysts (brensocatib, TPIP), which adds fundamental uncertainty beyond the technical picture. The signal is derived from a rules-based composite of RSI, moving averages, and MACD — not investment advice.
Technical Data Panel
Support & Resistance
- $100.00–$102.00
- $90.40–$93.00
- $85.00–$87.50
- $115.00–$118.00
- $130.00–$135.00
- $150.00–$155.00
Trend Direction
About the Data
This page displays technical indicators for INSM sourced from Financial Modeling Prep (FMP) and Massive API, two independent market data providers. Where both sources agree on the trend direction, the cross-validation badge shows green. When they diverge, the badge turns red — a signal to approach the data with extra caution. All values are for informational purposes only and may be delayed. They do not constitute financial advice or trading recommendations. Always verify technical levels on a live chart before making a trading decision.
Related Analysis
Create Your Own Pine Script Strategy
Use Pineify to generate custom TradingView indicators and strategies based on your own technical analysis ideas — no coding required.
Try Pine Script Generator